CliffBio
small molecule

AMIODARONE HYDROCHLORIDE

AMIODARONE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameAMIODARONE HYDROCHLORIDE
Active ingredientAMIODARONE HYDROCHLORIDE
Strength400MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2002
Marketing statusDISCN

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.